Literature DB >> 25835195

Key emerging themes for assessing the cost-effectiveness of reporting incidental findings.

Kathryn A Phillips1, Uri Ladabaum2, Mark J Pletcher3, Deborah A Marshall4, Michael P Douglas5.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25835195      PMCID： PMC4395812          DOI： 10.1038/gim.2015.13

Source DB:  PubMed          Journal:  Genet Med        ISSN： 1098-3600            Impact factor:   8.822


× No keyword cloud information.
  3 in total

Review 1.  Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelines.

Authors:  Stefan Vegter; Cornelis Boersma; Mark Rozenbaum; Bob Wilffert; Gerjan Navis; Maarten J Postma
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

2.  Genomic sequencing: assessing the health care system, policy, and big-data implications.

Authors:  Kathryn A Phillips; Julia R Trosman; Robin K Kelley; Mark J Pletcher; Michael P Douglas; Christine B Weldon
Journal:  Health Aff (Millwood)       Date:  2014-07       Impact factor: 6.301

3.  The cost-effectiveness of returning incidental findings from next-generation genomic sequencing.

Authors:  Caroline S Bennette; Carlos J Gallego; Wylie Burke; Gail P Jarvik; David L Veenstra
Journal:  Genet Med       Date:  2014-11-13       Impact factor: 8.822
  3 in total
  4 in total

1.  "What Goes Around Comes Around": Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine.

Authors:  Kathryn A Phillips; Michael P Douglas; Julia R Trosman; Deborah A Marshall
Journal:  Value Health       Date:  2017-01       Impact factor: 5.725

Review 2.  Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions.

Authors:  Kathryn A Phillips; Patricia A Deverka; Deborah A Marshall; Sarah Wordsworth; Dean A Regier; Kurt D Christensen; James Buchanan
Journal:  Value Health       Date:  2018-08-08       Impact factor: 5.725

3.  Response to Phillips et al.

Authors:  Caroline S Bennette; Wylie Burke; Gail P Jarvik; David L Veenstra
Journal:  Genet Med       Date:  2015-04       Impact factor: 8.822

Review 4.  Economic evidence on identifying clinically actionable findings with whole-genome sequencing: a scoping review.

Authors:  Michael P Douglas; Uri Ladabaum; Mark J Pletcher; Deborah A Marshall; Kathryn A Phillips
Journal:  Genet Med       Date:  2015-05-21       Impact factor: 8.822
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.